Antibody Drug Conjugate Market Sales Revenue Opportunity Report

Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the tumor cell or tissue.

Download Report:

https://www.kuickresearch.com/report-Antibody-Drug-Conjugate-Market-Opportunity-Analysis.php

For Report Sample Contact: neeraj@kuickresearch.com or +91-11-47067990

" Antibody Drug Conjugate Market Opportunity Analysis" Table of Contents

1. Introduction to Antibody Drug Conjugate

2. Antibody Drug Conjugate Mechanism
2.1 Components of Antibody Drug Conjugate
2.2 Mechanism of Antibody Drug Conjugate

3. Why Need for Antibody Drug Conjugate?

4. Antibody Drug Conjugate Market Outlook
4.1 Market Overview
4.2 Anti Drug Conjugate Clinical Pipeline Analysis

5. Antibody Drug Conjugate Market Dynamics
5.1 Market Acceptability Drivers
5.2 Issues to be Addressed
5.3 Future Growth Opportunities

6. Antibody Drug Conjugate Clinical Trial Insight by Phase & Target Indications
6.1 Research
6.2 Preclinical
6.3 Phase I
6.4 Phase I/II
6.5 Phase II
6.6 Phase II/III
6.7 Phase III

7. Marketed Antibody Drug Conjugate

8. Competitive Landscape
8.1 ADC Therapeutics
8.2 Agensys
8.3 Ambrx
8.4 Amgen
8.5 AREVA Med
8.6 Bayer HealthCare
8.7 Genentech
8.8 Immunomedics
8.9 ImmunoGen
8.10 Seattle Genetics

Figure 2-1: Components of Antibody Drug Conjugate
Figure 2-2: Mechanism of Antibody Drug Conjugate
Figure 4-1: Global Antibody Drug Conjugate Market (US$ Billion), 2013-2020
Figure 4-2: Global Adcetris Sales (Million US$), 2013 & 2020
Figure 4-3: Adcetris Sales in US & Europe (Million US$), 2013
Figure 4-4: Global Kadcyla Sales (Million US$), 2013 & 2020
Figure 4-5: Kadcyla Market in US & Ex US (Million US$), 2013
Figure 4-6: Antibody Drug Conjugate Clinical Pipeline by Phase (%)
Figure 4-7: Antibody Drug Conjugate Clinical Pipeline by Phase (%)

List of Tables

Table 8-1: ADC Therapeutics Clinical Pipeline
Table 8-2: Agensys Clinical Pipeline
Table 8-3: Ambrx Clinical Pipeline
Table 8-4: Amgen Clinical Pipeline
Table 8-5: AREVA Med Clincal Pipeline
Table 8-6: Genentech Clinical Pipeline
Table 8-7: Immunomedics Clinical Pipeline
Table 8-8: ImmunoGen Clinical Pipeline
Table 8-9: Seattle Genetics Clinical Pipeline
Need custom market research solution? We can help you with that too

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

+91-11-47067990eeraj Chawla
neeraj@kuickresearch.com
KuicK Research
Avanta Business Center 4th Floor,
Statesman House Barakhamba Road,
Connaught Place New Delhi – 110 001, India

This release was published on openPR.